Aurinia Pharmaceuticals
$15.61
133
+$0.14+0.9% Thursday 20:00
Statistics
Day High
15.69
Day Low
15.06
52W High
16.54
52W Low
6.83
Volume
1,223,046
Avg. Volume
1,069,303
Mkt Cap
2.08B
P/E Ratio
30.63
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30AprExpected
Expected EPS
0.195
Actual EPS
N/A
Financials
101.47%Profit Margin
Profitable566.11MRevenue
574.4MNet Income
Analyst Ratings
$17.33Average Price Target
The highest estimate is 21.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 33%
Hold 67%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow AUPH. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap94.51B
Abbvie
ABBV
Mkt Cap385.18B
Pfizer
PFE
Mkt Cap140.15B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
AMGEN
AMGN
Mkt Cap160.66B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Novartis
NVS
Mkt Cap237.61B
Gilead Sciences
GILD
Mkt Cap148.78B
Astrazeneca
AZN
Mkt Cap256.58B
Roche
RHHBY
Mkt Cap258.9B
About
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Show more...
CEO
Mr. Peter S. Greenleaf M.B.A.
Employees
130
Country
CA
ISIN
CA05156V1022
Listings
0 Comments
Share your thoughts
FAQ
What is Aurinia Pharmaceuticals stock price today?▼
The current price of AUPH is $15.61 USD — it has increased by +0.9% in the past 24 hours. Watch Aurinia Pharmaceuticals stock price performance more closely on the chart.
What is Aurinia Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aurinia Pharmaceuticals stocks are traded under the ticker AUPH.
Is Aurinia Pharmaceuticals stock price growing?▼
AUPH stock has risen by +9.39% compared to the previous week, the month change is a +5.9% rise, over the last year Aurinia Pharmaceuticals has showed a +99.87% increase.
What is Aurinia Pharmaceuticals market cap?▼
Today Aurinia Pharmaceuticals has the market capitalization of 2.08B
When is the next Aurinia Pharmaceuticals earnings date?▼
Aurinia Pharmaceuticals is going to release the next earnings report on April 30, 2026.
What were Aurinia Pharmaceuticals earnings last quarter?▼
AUPH earnings for the last quarter are 1.53 USD per share, whereas the estimation was 0.22 USD resulting in a +606.15% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aurinia Pharmaceuticals revenue for the last year?▼
Aurinia Pharmaceuticals revenue for the last year amounts to 566.11M USD.
What is Aurinia Pharmaceuticals net income for the last year?▼
AUPH net income for the last year is 574.4M USD.
How many employees does Aurinia Pharmaceuticals have?▼
As of April 05, 2026, the company has 130 employees.
In which sector is Aurinia Pharmaceuticals located?▼
Aurinia Pharmaceuticals operates in the Health Care sector.
When did Aurinia Pharmaceuticals complete a stock split?▼
Aurinia Pharmaceuticals has not had any recent stock splits.
Where is Aurinia Pharmaceuticals headquartered?▼
Aurinia Pharmaceuticals is headquartered in Edmonton, CA.